Pure Global AI
ANVISA registration 10338930282Active

ANTIBODY FOR CELIAC DISEASE

ANVISA Registration Number: 10338930282EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAEUROIMMUN AGRisk Class II
Device names
Technical name
ANTIBODY FOR CELIAC DISEASE
PT: ANTICORPO PARA DOENÇA CELÍACA
Commercial name
IIFT: Endomísio Fígado de Macaco (IgA)
Risk class
Class II
Registration details
Registration Number
10338930282
Process Number
25351218271202284
CNPJ
93741726000166
Company information
Manufacturer
EUROIMMUN AG
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Aug 18, 2022
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930282 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.